University of North Carolina (UNC)
CB # 6000
312 South Building
Chapel Hill
North Carolina
27599-6000
United States
Tel: 919-962-2023
Fax: 919-962-0647
Website: http://www.unc.edu/
About University of North Carolina (UNC)
The University of North Carolina at Chapel Hill was the first state university to open its doors. The University was chartered in 1789, laid its first cornerstone on October 12, 1793, and opened officially on January 16, 1795. Now part of the 16-campus University of North Carolina system, the University of Chapel Hill is ranked among the great institutions of higher education in the nation, and one of the foremost graduate and research institutions in the country.Today's institution at Chapel Hill is made up of 14 colleges and schools, including numerous institutes and research centers. Student enrollment is over 23,000. Bachelor's degrees are offered in over 69 fields of study, master's degrees in 87, the Ph.D. in 59, and professional degrees are given in 11 schools.
Led by Chancellor James Moeser, the University is in the midst of its Bicentennial Campaign, seeking $320 million to support Carolina's mission of excellence in teaching, research, and public service.
Last Updated: 01-14-04
303 articles with University of North Carolina (UNC)
-
Acer Therapeutics Announces University of NC Receives Department of Defense Grant to Support the Proposed Investigator Sponsored OASIS Trial of ACER-801 (Osanetant) to Reduce the Frequency and Severity of Post-Traumatic Stress Disorder
10/6/2022
Acer Therapeutics Inc. announced that the University of North Carolina Institute for Trauma Recovery has been awarded a $3 million grant from the Department of Defense to investigate the potential of ACER-801 to reduce the frequency and severity of acute stress disorder and post-traumatic stress disorder.
-
In a small study of 14 rectal cancer patients, researchers at Memorial Sloan Kettering Cancer Center published results where 100% of the 12 patients who completed treatment went into remission.
-
COVID-19 vaccines are the most-studied vaccines in history. This is partly why some data can appear so contradictory. For those and more COVID-19 stories, continue reading.
-
While the "speed of science" to develop a successful coronavirus vaccine against the novel COVID-19 has been record-setting, scientists are telling us it's not enough.
-
While modern-day science has provided the world with highly effective vaccines to fight the COVID-19 pandemic, researchers have had less luck finding effective treatment options for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
-
UNC Health Administers Its 100,000th COVID-19 Vaccine Shot
2/2/2021
UNC Health passed a significant milestone , administering its 100,000th COVID-19 vaccine dose.
-
US researchers seeking 6,000+ participants for world's largest eating disorders genetics study
10/13/2020
University of North Carolina researchers are seeking more than 6,000 participants aged 18 years and over, with first-hand experience of eating disorders to enroll in the world's largest ever genetic research study into three complex, devastating mental illnesses.
-
EMBARGOED: 12:01AM ET, TUESDAY, OCTOBER 13, 2020: US Researchers Seeking 6,000+ Participants for World’s Largest Eating Disorders Genetics Study
10/12/2020
Tomorrow, University of North Carolina researchers will call for more than 6,000 participants aged 18 years and over, with first-hand experience of an eating disorder to enroll in the world’s largest ever genetic research study into three complex and devastating mental illnesses.
-
AskBio Enters Research Collaboration and Licensing Agreement with University of North Carolina (UNC) for Angelman Syndrome
3/18/2020
Collaboration builds upon preclinical research that demonstrates potential for gene therapy to correct deficiency in UBE3A gene
-
The experimental patch monitors glucose levels and has doses of insulin pre-loaded in micro-needles.
-
Anchored by Raleigh, Durham and the Research Triangle Park region, BioSpace’s Bio NC Hotbed is one of the faster-growing areas for biopharma in the U.S.
-
Ribometrix closed on a Series A financing worth $30 million. The round was led by M Ventures, with participation of new investors Amgen Ventures, Pappas Capital and Illumina Ventures.
-
October 19 Research Roundup: Dementia, Frankenstein Proteins, and Epigenetic Sperm Changes
10/19/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Study Finds Equashield is One of Only Two Truly Closed Systems as Defined by Original NIOSH Protocol
9/4/2018
University of North Carolina's Eshelman School of Pharmacy study published in the Journal of Oncology Pharmacy Practice
-
UNC Health Care CEO, Medical School Dean Bill Roper Plans to Step Down in 2019
5/31/2018
Dr. William L. Roper, who has helped transform UNC Health Care and the UNC School of Medicine into one of the nation’s top academic medical institutions, plans to step down as CEO and dean in May 2019.
-
Love Handles Get Dissolved By New Skin Patch, University of North Carolina Study Reveals
9/18/2017
-
AI Predicts Autism By Comparing Babies' Brains, University of North Carolina Study
2/27/2017
-
Dying From Cancer: Where You Live Could Determine Your Fate, University of North Carolina Study Reveals
1/25/2017
-
Bloomin’ Marvellous: Flower Power Helps Medtech, University of North Carolina Study
1/3/2017
-
University of North Carolina Release: Scientists Find New Way To Reverse Immune Suppression Caused By HIV
12/16/2016